MarketPulse — Real-Time Financial News & Market Analysis

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.

Global cytokines market projected to grow from $95.32B (2025) to $174.53B (2032) at 9.02% CAGR, driven by manufacturing advances and strategic partnerships.

Tesla must submit crash data to NHTSA on March 9 regarding Full Self-Driving probe, creating significant near-term volatility risk amid weakening EV sales.

Global genomics services market projected to grow from $7.94B in 2025 to $25.18B by 2035, driven by rising genetic disorder prevalence and precision medicine initiatives.

Vertiv offers an alternative AI infrastructure play through data center power and cooling systems, boasting 252% YOY order growth and $15 billion backlog amid projected data center spending surge.

China's intelligent automotive fragrance market projected to exceed 4 million units by 2030, driven by new health standards and integrated purification demand.

Nvidia stock has surged 1,100% in three years on AI dominance. Analysts debate whether $300 target by 2026 is achievable or if $250 is more realistic.

AST SpaceMobile, Alphabet's largest investment holding, surged 2,800% in two years amid institutional enthusiasm. The satellite broadband provider trades at premium valuation with significant execution risks.

Oculis plans March 2026 investor conferences highlighting six pivotal clinical readouts, including Privosegtor's breakthrough optic neuritis program and OCS-01 Phase 3 results expected Q2 2026.

Qfin Holdings will report Q4 and full year 2025 financial results on March 17, 2026, via earnings call.

Oculis files 2025 audited financial statements with SEC via Form 20-F and announces investor conference participation, signaling transparent capital markets engagement.

Wolters Kluwer repurchased 80,106 shares for €5.5M in early March 2026, bringing year-to-date buybacks to €109.3M of its €500M program.

Oculis announces March 2026 investor conference participation, showcasing pipeline advances including Privosegtor's optic neuritis breakthrough designation and anticipated Phase 3 readouts.

Nvidia CEO Jensen Huang declares the company's $30 billion OpenAI investment likely final before IPO, scaling back from proposed $100 billion infrastructure deal.

Analysts project Nvidia to reach $285 by end of 2026, representing 58% upside, driven by dominant AI infrastructure position and strong data center growth tailwinds.

Credo Technology posts 201% YoY growth and 68.5% margins from AI infrastructure dominance, but $19B valuation and extreme customer concentration create significant downside risk.

JetBlue canceled 22% of winter flights versus single-digit competitor rates, costing $30-40M, but core assets remain intact with potential three-year recovery.

Palantir's 56% revenue growth and 50% operating margin make it a superior AI investment compared to trendy prediction markets like Polymarket.

Experts warn three catalysts—record valuations, Middle East escalation, and Federal Reserve confusion—pose greater market risks than tariffs in 2026.

S&P 500 gains face headwinds from elevated volatility, liquidity constraints, and technical resistance as oil tensions persist near $78.